Artificial intelligence proves its use in cancer diagnosis

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Identifying cancer based on blood samples can be surprisingly challenging. Often, doctors add chemicals to a sample that can make the cancerous cells visible, but that makes the sample impossible to use in other tests. Other techniques identify cancerous cells based on their abnormal structure, but those take more time (those cells are often rare in a given sample) and can misidentify healthy misshapen cells as cancerous.

Now researchers at University of California Los Angeles have developed a technique that combines a special microscope with an artificial intelligence algorithm to non-destructively identify cancer in a sample. Not only can that reduce the time and energy needed to diagnose cancer (and, thus, allow doctors to treat it more quickly), but could also be an asset for the field of precision medicine. The researchers published a paper about their technique recently in the journal Scientific Reports.

The microscope is called a photonic time stretch microscope, which uses nanosecond-long pulses of light broken into lines to capture images of hundreds of thousands of cells per second. Those images are fed into a computer program, which categorizes 16 of the cells’ different physical features, such as diameter, circularity, and how much light they absorb.

Read full, original post: Artificial intelligence helps diagnose cancer

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend